Carl Blomqvist

发表

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

Jane E. Carpenter, Kyriaki Michailidou, France Labrèche, 2014, Human molecular genetics.

Effect of image compression and scaling on automated scoring of immunohistochemical stainings and segmentation of tumor epithelium

Nina Linder, Mikael Lundin, Johan Lundin, 2012, Diagnostic Pathology.

Identification of genetic markers with synergistic survival effect in cancer

Pekka Manninen, Jianjun Liu, Sampsa Hautaniemi, 2013, BMC Systems Biology.

Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

Julian Peto, Matthias W. Beckmann, Peter A. Fasching, 2014, PLoS genetics.

CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies.

Nazneen Rahman, Michael Bremer, Julian Peto, 2004, American journal of human genetics.

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.

Peter Kraft, Todd L Edwards, Nazneen Rahman, 2016, Cancer discovery.

Screening of HELQ in breast and ovarian cancer families

Heli Nevanlinna, Kristiina Aittomäki, Carl Blomqvist, 2015, Familial Cancer.

Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients

Thilo Dörk, Annegien Broeks, Heli Nevanlinna, 2009, Breast Cancer Research.

Identification of Novel Genetic Markers of Breast Cancer Survival

Peter Kraft, Nazneen Rahman, Janet A. Dunn, 2015, Journal of the National Cancer Institute.

Breast cancer on the Internet: the quality of Swedish breast cancer websites.

Gerhard Andersson, Carl Blomqvist, Per Edlund, 2004, Breast.

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

Päivi Heikkilä, Jiri Bartek, Heli Nevanlinna, 2005, International journal of cancer.

A Genome-wide Association Scan on Estrogen Receptor-negative Breast Cancer

Anbupalam Thalamuthu, Kamila Czene, Per Hall, 2022 .

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Michael Jones, Peter Kraft, Arnaud Droit, 2017, Nature Genetics.

Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

Peter Kraft, Michael Bremer, Simon S. Cross, 2008, PLoS genetics.

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families

Päivi Heikkilä, Heli Nevanlinna, Kristiina Aittomäki, 2004, Breast Cancer Research.

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

Päivi Heikkilä, Carlos Caldas, Arto Mannermaa, 2014, The journal of pathology. Clinical research.

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

Daniel J. Park, Julian Peto, Kamila Czene, 2012, Cancer research.

A network analysis to identify mediators of germline-driven differences in breast cancer prognosis

Gary D. Bader, Christine L. Clarke, Gary D Bader, 2020, Nature Communications.

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Wei Lu, Wei Zheng, Mads Thomassen, 2013, Nature Genetics.

BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition

Heli Nevanlinna, Kristiina Aittomäki, Carl Blomqvist, 2006, European Journal of Human Genetics.

A Genome-wide Association Study of Early-Onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age

Jianxin Shi, Daniel F. Schmidt, Nazneen Rahman, 2014, Cancer Epidemiology, Biomarkers & Prevention.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Dong Liang, Patrick Neven, Harvey Risch, 2016, Journal of the National Cancer Institute.

MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer

Päivi Heikkilä, Jiri Bartek, Dario Greco, 2011, PloS one.

Variants on the promoter region of PTEN affect breast cancer progression and patient survival

Päivi Heikkilä, Dario Greco, Heli Nevanlinna, 2011, Breast Cancer Research.

SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival

Bernd Holleczek, Peter A. Fasching, Simon S. Cross, 2015, Oncotarget.

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Y Wang, Mike Clarke, Donald A. Berry, 2005, The Lancet.

Distribution of coronary artery stenosis after radiation for breast cancer.

Hans Garmo, Carl Blomqvist, L. Holmberg, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170

Wei Zheng, Mads Thomassen, Nicholas A. Sinnott-Armstrong, 2016 .

NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer

Päivi Heikkilä, Jiri Bartek, Arto Mannermaa, 2008, Nature Genetics.

Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

Patrick Neven, Hui Zhao, Nazneen Rahman, 2012, PloS one.

Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy.

Carl Blomqvist, Mattias Berglund, C. Blomqvist, 2007, Blood.

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

Patrick Neven, Päivi Heikkilä, Giu-Cheng Hsu, 2011, Human molecular genetics.

Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.

Michael Jones, Nazneen Rahman, Michael Bremer, 2011, Human molecular genetics.

A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.

Julian Peto, Kyriaki Michailidou, Thomas Brüning, 2014, Human molecular genetics.

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Patrick Neven, Peter Kraft, Nazneen Rahman, 2015 .

No germline FH mutations in familial breast cancer patients

Heli Nevanlinna, Kristiina Aittomäki, Carl Blomqvist, 2005, European Journal of Human Genetics.

Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies

Päivi Heikkilä, Carlos Caldas, Simon S. Cross, 2010, PLoS medicine.

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.

Wei Lu, Päivi Heikkilä, Peter Kraft, 2013, American journal of human genetics.

Genome-wide association studies identify four ER negative–specific breast cancer risk loci

Patrick Neven, Michael Jones, Wei Lu, 2013, Nature Genetics.

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

Patrick Neven, Chiun-Sheng Huang, Julian Peto, 2014, Breast Cancer Research.

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

Jane E. Carpenter, Peter Kraft, Gary K. Chen, 2011, Nature Genetics.

PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS

Dong Liang, Jane E. Carpenter, Peter Kraft, 2016 .

Evaluation of RAD50 in familial breast cancer predisposition

Päivi Heikkilä, Jiri Bartek, Nazneen Rahman, 2006, International journal of cancer.

ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer

Joan E Bailey-Wilson, Heli Nevanlinna, Rainer Fagerholm, 2008, European Journal of Human Genetics.

11q13 is a susceptibility locus for hormone receptor positive breast cancer

Patrick Neven, Michael Jones, Michael Bremer, 2012, Human mutation.

A combined analysis of genome-wide association studies in breast cancer

Anbupalam Thalamuthu, Kamila Czene, Maartje J. Hooning, 2011, Breast Cancer Research and Treatment.

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

Wei Lu, Nina Ditsch, Julian Peto, 2013, American journal of human genetics.

Tamoxifen for early breast cancer: an overview of the randomised trials

Mike Clarke, Luc Bijnens, Michael Gnant, 1998, The Lancet.

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

Matthias W. Beckmann, Peter A. Fasching, Nur Aishah Mohd Taib, 2014, Nature Communications.

CHEK2 variant I157T may be associated with increased breast cancer risk

Päivi Heikkilä, Jiri Bartek, Heli Nevanlinna, 2004, International journal of cancer.

Genome-wide association analysis identifies three new breast cancer susceptibility loci

Michael Jones, Nazneen Rahman, Daniel J. Park, 2012, Nature Genetics.

Breast Cancer Patients with p53 Pro72 Homozygous Genotype Have a Poorer Survival

Päivi Heikkilä, Heli Nevanlinna, Kristiina Aittomäki, 2005, Clinical Cancer Research.